The SUFFICE-CoV Study [COVID-19]

• Research type

  Research Study

• Full title

  Success Factors Facilitating Care during Escalation in the Covid-19 pandemic

• IRAS ID

  283418

• Contact name

  Jody Ede

• Contact email

  jody.ede@ouh.nhs.uk

• Sponsor organisation

  Oxford University Hospitals NHS

• Duration of Study in the UK

  3 years, 0 months, 1 days

• Research summary

  Why research care escalation?
  Yearly, up to 40,000 hospital patients suffer a preventable death because staff inadequately recognise patient illness or there are delays in a medical review (escalation of care). This widespread problem has been identified in NHS care reviews and current research focuses on why escalation does not always happen. However, further reductions to patient deaths are possible, by examining care of unwell hospital patients who are successfully managed and identifying success factors to escalation of care.

  Why research escalation of care now?
  Covid-19 provides a grim opportunity to examine care escalation in two distinct patient groups, Covid-19 positive and negative patients. As the NHS has had to modify care delivery models, success factors may be evident to inform future care delivery. There is no research currently detailing how deteriorating Covid-19 patients are detected, assessed, or managed during care escalation. This would be the first study to address these gaps.

  What are the aims of the study?

  The aim of SUFFICE-CoV is to develop a framework of success factors that can inform refinements to the escalation of care (rescue) process resulting in improved deteriorating patient outcomes.

  How will the aim be achieved?

  Phase 1: Staff observations during escalation events
  I will observe around between 200-400 care escalation events detailing staff interactions for Covid-19 positive and negative patients.

  Phase 2: Care record Reviews
  I will review between 200-400 Covid-19 positive and negative patient care records (nursing and medical documentation) from patients who deteriorated, improved and were not admitted to ICU.

  Phase 3: Staff Interviews
  I will talk to 30 expert doctors and nurses to identify: escalation success factors, how these could be applied effectively and the impact of pandemic care models

  Phase 4: Data Analysis and Integration phase
  See below

• REC name

  London - Queen Square Research Ethics Committee

• REC reference

  20/HRA/3828

• Date of REC Opinion

  5 Oct 2020

• REC opinion

  Further Information Favourable Opinion